Key stats
About Neurocrine Biosciences, Inc.
Sector
CEO
Kevin Charles Gorman
Headquarters
San Diego
Website
Founded
1992
ISIN
BRN1BIBDR009
FIGI
BBG00XV3YMP3
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It discovers, develops, and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where N1BI34 is featured.